This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Leonard Hersher, MD
Department of Pediatrics SUNY/Health Science Center 750 E Adams St Syracuse, NY 13210

Am J Dis Child. 1987;141(3):239-240.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sir.—A recent editorial¹ concluded that "pharmacologic treatments of hyperactivity and attention deficit disorder [ADD] with stimulant therapies have had disappointing long-term outcome measures." True. The same conclusion can be made about insulin treatment of diabetes mellitus if treatment is stopped at age 13 years, which is a common practice for ADD.

One tends to forget that ADD is a chronic problem and must be treated as such. In fact, when adolescents receive stimulants for ADD, they generally respond well.^2-6 The problem continues into adulthood, and adults' conditions, too, improve with stimulant therapy.^7-12 Attention deficit disorder is most probably an inborn disorder of the central nervous system, and inborn disorders of that nature have a propensity to hang on for life. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?